Inventor
OKAJIMA DAISUKE
JP14 patents
⚠️ This page may combine multiple inventors who share the name “OKAJIMA DAISUKE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DAIICHI SANKYO CO LTD
11 patentsUS9850312B2Dec 26, 2017
Anti-TROP2 antibody-drug conjugate
DAIICHI SANKYO CO LTD64 citations96
US10227417B2Mar 12, 2019
Anti-TROP2 antibody-drug conjugate
DAIICHI SANKYO CO LTD27 citations93
US12246196B2Mar 11, 2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines
DAIICHI SANKYO CO LTD1 citations72
US11628223B2Apr 18, 2023
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines
DAIICHI SANKYO CO LTD1 citations71
US11583590B2Feb 21, 2023
Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor
DAIICHI SANKYO CO LTD1 citations71
US11008398B2May 18, 2021
Anti-TROP2 antibody-drug conjugate
DAIICHI SANKYO CO LTD3 citations71
US11173213B2Nov 16, 2021
Method for selectively manufacturing antibody-drug conjugate
DAIICHI SANKYO CO LTD3 citations67
US12350344B2Jul 8, 2025
Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate
DAIICHI SANKYO CO LTD0 citations60
US7527937B2May 5, 2009
Assay employing a g-protein coupled receptor that is activated by CCK-8S
DAIICHI SANKYO CO LTD2 citations59
US7977069B2Jul 12, 2011
DNA encoding a CCK-8S G-protein coupled receptor, and vectors, transformants, cell kits, and methods employing such DNA
DAIICHI SANKYO CO LTD0 citations49
US12312641B2May 27, 2025
Sensitivity marker for antibody-drug conjugate
DAIICHI SANKYO CO LTD0 citations44